In order to elucidate the underlying mechanism of GCS inhibition-increased cisplatin-induced CCA cell death (i.e., in KKU-213A cells), GCS was suppressed by 10 μM PPMP and co-treated with 10 or 20 μM cisplatin. The gene discussed is UGCG; the disease is cholangiocarcinoma.